T44.7X2A Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, initial encounter

Name of the Condition

• Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, initial encounter
• This code represents intentional self-harm poisoning from beta-adrenoreceptor antagonists (beta-blockers) during the first encounter with the condition.

Summary

Intentional self-harm poisoning by beta-adrenoreceptor antagonists occurs when a patient deliberately ingests or is exposed to excessive amounts of beta-blockers, leading to toxic effects. Beta-blockers are medications used to manage cardiovascular conditions like hypertension, angina, and arrhythmias. The initial encounter indicates the first time the patient seeks care for this poisoning.

Causes

Intentional self-harm poisoning may result from deliberate overdose, misuse of prescribed medications, or intentional exposure to beta-blockers. It can also occur due to intentional ingestion of higher-than-prescribed doses or improper administration of the drug.

Risk Factors

• Concurrent use of multiple medications affecting cardiovascular function.
• Pre-existing conditions that alter drug metabolism or sensitivity (e.g., asthma, diabetes).
• Age-related changes in drug response (e.g., elderly or pediatric patients).
• History of substance use or misuse.
• Mental health conditions or suicidal ideation.

Symptoms

• Bradycardia (slow heart rate) or tachycardia (rapid heart rate).
• Fatigue, dizziness, or syncope.
• Cold extremities or Raynaud’s phenomenon.
• Hypotension (low blood pressure).
• Respiratory distress or bronchospasm.
• Seizures or altered mental status.

Diagnosis

Diagnosis involves clinical assessment of symptoms, patient history (including intentional self-harm), and laboratory tests to confirm beta-blocker exposure. Electrocardiogram (ECG) may show bradycardia, hypotension, or conduction abnormalities. Toxicology screening can identify the specific beta-blocker and quantify levels.

Treatment Options

Treatment focuses on stabilizing the patient, reversing toxicity, and managing complications. Interventions may include activated charcoal (if ingestion is recent), supportive care (e.g., fluids, oxygen), and medications like glucagon or high-dose insulin to counteract beta-blocker effects. In severe cases, mechanical ventilation or pacemaker placement may be necessary.

Prognosis and Follow-Up

Prognosis depends on the dose ingested, time to treatment, and patient factors. Early intervention improves outcomes. Follow-up includes monitoring for recurrence, addressing underlying mental health concerns, and ensuring medication safety. Long-term care may involve psychiatric evaluation and support.

Complications

• Severe bradycardia or cardiac arrest.
• Hypotension leading to shock.
• Respiratory failure or bronchospasm.
• Neurological damage from hypoxia.
• Multi-organ failure in severe cases.

Lifestyle & Prevention

Prevention involves secure storage of medications, education on proper dosing, and addressing mental health needs. Patients with a history of self-harm should have access to support resources and medication management plans. Family members should be aware of signs of overdose and emergency protocols.

When to Seek Professional Help

Seek immediate medical attention if intentional self-harm with beta-blockers is suspected, or if symptoms like severe dizziness, fainting, or difficulty breathing occur. Emergency care is critical to prevent life-threatening complications.

Tips for Medical Coders

Document the intent (intentional self-harm) and encounter type (initial) clearly. Include details on the beta-blocker involved, timing of exposure, and clinical findings. Ensure the code aligns with the patient’s diagnosis and treatment documentation.